抗菌释放型钛硅复合种植体基材对抗口腔生物膜的体外研究
本研究开发了载氯己定(CHX)的钛硅(Ti/SiO2)复合种植体基材,采用增材制造多孔钛合金盘与溶胶-凝胶介孔二氧化硅屏障实现控释。体外多菌种生物膜实验显示,载药基材较对照组活菌减少≥2 log10,并能抑制致病菌和代谢产酸;结论支持其作为种植体周围炎防治新策略的可行性。
要点
- Ti/SiO2基材平均孔径5.6 nm,CHX-DA释放速率约0.00077 mmol/L/天。
- 载药基材使活菌数较对照降低≥2 log10,并减少代谢酸产生。
- CHX-DA与Corsodyl均能有效抑制致病菌,SEM可见细菌形态改变。
核心结论
- 抗菌释放型Ti/SiO2种植体盘在体外展现持续抑制和治療生物膜的功效,提示其作为种植体周围炎管理未来策略的可行性。
研究设计与样本
- 体外研究:采用增材制造多孔Ti6Al4V盘与溶胶-凝胶介孔SiO2屏障构建Ti/SiO2插入件,测试CHX-DA或Corsodyl的释放,以PBS和BHI-2为对照,所有实验重复四次。
主要发现
- 盘平均孔径为5.6 nm,CHX-DA释放速率约为0.00077 mmol/L/天。
- 载抗菌剂插入件生物膜形成减少,活菌较对照降低≥2 log10。
- CHX-DA和Corsodyl有效抑制致病菌并减少代谢酸产生。
- SEM显示处理表面细菌细胞形态发生变化。
关键数值与推荐
- 平均孔径5.6 nm,CHX-DA释放速率约0.00077 mmol/L/天。
- 活菌减少≥2 log10(与对照相比)。
临床怎么用
- 该体外结果支持抗菌释放型Ti/SiO2基材作为种植体周围炎局部防治的潜在方向,但尚未提供临床推荐。
局限性
- 研究为体外设计,实验重复四次,未报告临床或体内验证数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Peri-implantitis, a biofilm-associated inflammatory disease, significantly threatens dental implant longevity. Current treatments face limitations due to biofilm robustness. This study evaluates the efficacy of antimicrobial-releasing titanium-silica (Ti/SiO2) composite implant systems against multispecies oral biofilms, aiming to advance innovative localized and targeted peri-implantitis prevention and management strategies. MATERIALS AND METHODS: Ti/SiO2 inserts were engineered with macroporous Ti6Al4V discs produced by additive manufacturing (AM) and a sol-gel-derived mesoporous SiO2 barrier for controlled antimicrobial release across the discs. Chlorhexidine (CHX), as the gold standard antimicrobial agent in dental practice, was tested for its release efficacy using either a laboratory-prepared chlorhexidine diacetate solution (CHX-DA) or the commercial formulation Corsodyl. Phosphate-buffered saline (PBS) and Brain Heart Infusion-2 (BHI-2) medium served as control solutions. After establishing the CHX-DA release profile, multispecies biofilms were grown on the inserts. The antimicrobial efficacy of the release systems was assessed via viability-qPCR, scanning electron microscopy (SEM), and metabolic acid profiling. All experiments were conducted four times. RESULTS: A mean pore diameter of 5.6 nm was observed for the discs, resulting in a steady drug release rate (≈0.00077 mmol/L CHX-DA/day). The antimicrobial-fed inserts showed less biofilm formation, with ≥ 2 log10 reductions in viable bacteria compared to controls. CHX-DA and Corsodyl showed effective suppression of pathogenic bacteria and reductions in metabolic acid production. SEM analysis revealed morphological changes in bacterial cells on treated surfaces. CONCLUSION: Antimicrobial-releasing Ti/SiO2 implant discs demonstrated sustained efficacy in biofilm prevention and treatment, indicating their feasibility as a future strategy for peri-implantitis management.
引用
- Kamarudin NHN, Vanmunster L, Van Hooreweder B, et al. Antimicrobial-Releasing Implant Substrates for Combating Oral Biofilms: An In Vitro Study. Clin Oral Implants Res. 2025. PMID: 41217191. doi:10.1111/clr.70067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。